Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astrazeneca Plc ADR
(NQ:
AZN
)
77.99
-0.19 (-0.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astrazeneca Plc ADR
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
55
56
Next >
The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu
April 19, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
UK-Based Start-Up Working On Next COVID-19 Vaccine Using Animal Feces: FT
April 19, 2022
Via
Benzinga
Daiichi Sankyo - AstraZeneca's Enhertu Receives Priority Review In US For Lung Cancer
April 19, 2022
Via
Benzinga
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
April 19, 2022
From
AstraZeneca
Via
Business Wire
AstraZeneca Bets $25M On Preclinical Bispecific Antibody
April 07, 2022
Via
Benzinga
Danaher Joins Elite List Of Stocks With 95-Plus Composite Rating
April 06, 2022
On Wednesday, Danaher got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96.
Via
Investor's Business Daily
Japan's Health Ministry Panel OKs Approval Of Novavax's COVID-19 Vaccine: Report
April 18, 2022
Via
Benzinga
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
April 18, 2022
In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a...
Via
Benzinga
After Encouraging Data, Blueprint Medicines Plans Combination Cohort In Tagrisso Resistant Lung Cancer
April 11, 2022
Blueprint Medicines Corp (NASDAQ: BPMC)
Via
Benzinga
Syros' CDK12 Inhibitor Shows Anti Tumor Activity In Preclinical Studies
April 11, 2022
Syros Pharmaceuticals Inc (NASDAQ: SYRS)
Via
Benzinga
Seagen Wins $42M Patent Claim Against Daiichi In Cancer Drug Case
April 11, 2022
A jury in Marshall, Texas, awarded Seagen Inc (NASDAQ: SGEN)
Via
Benzinga
Week In Review: Harbour BioMed Signs $350 Million Out-license Deal For Bispecific With AstraZeneca
April 09, 2022
Harbour BioMed out-licensed global rights for a pre-clinical bispecific candidate to AstraZeneca in a $350 million agreement. Harbour BioMed will receive $25 million upfront and as much as $325 million...
Via
Talk Markets
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.
Via
InvestorPlace
7 Desirable Dividend Growth Stocks for Income Investors
April 08, 2022
As the market starts to get a little bumpier, these dividend stocks offer growth with more than a little safety built-in.
Via
InvestorPlace
What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates?
April 07, 2022
Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier.
Via
Benzinga
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
April 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high...
Via
Benzinga
FDA Official Says Frequent COVID-19 Booster Shows Not Sustainable: WSJ
April 07, 2022
According to a U.S. health regulator, asking people to get COVID-19 boosters frequently wasn't sustainable because of vaccine fatigue, and authorities needed to develop a long-term strategy for...
Via
Benzinga
Here's How Much You Would Have Made Owning AstraZeneca Stock In The Last 5 Years
April 06, 2022
AstraZeneca (NASDAQ:AZN) has outperformed the market over the past 5 years by 4.32% on an annualized basis producing an average annual return of 18.01%. Currently, AstraZeneca has a market...
Via
Benzinga
AstraZeneca's Ultomiris Shows Sustained Improvements In Functional Activities In Neuromuscular Disease
April 06, 2022
Via
Benzinga
ULTOMIRIS® (ravulizumab-cwvz) demonstrated sustained improvements in functional activities and quality of life in adults with generalized myasthenia gravis through 60 weeks
April 06, 2022
From
AstraZeneca
Via
Business Wire
Ionis Pharma - AstraZeneca Antisense Medicine Met Its Primary, Secondary Goals To Lower Cholesterol
April 04, 2022
Ionis Pharmaceuticals Inc (NASDAQ: IONS) and its partner, AstraZeneca Plc (NASDAQ: AZN), have
Via
Benzinga
Top Nasdaq 100 Stocks: Trading Opportunities For Next Week
April 03, 2022
A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Let's look at some Nasdaq 100 stock opportunities by...
Via
Talk Markets
Mitt Romney Says Senators Reached Tentative $10B Deal In Additional COVID-19 Relief Funding: CNBC
April 01, 2022
Via
Benzinga
Omicron More Severe For Unvaccinated Children Than Other Strains, Hong Kong Study Finds: Bloomberg
March 31, 2022
According to a Hong Kong-based study, the omicron variant of COVID-19 has been linked to more hospitalizations, severe complicat
Via
Benzinga
3 Vaccine Stocks to Buy on the New Covid Variant Surge
March 31, 2022
These vaccine stocks are likely to trend higher with the recent surge in covid-19 cases and concerns related to a new variant.
Via
InvestorPlace
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
March 30, 2022
According to the Centers for Disease Control and Prevention estimates, the omicron BA.2 variant represents approximately 55% of new COVID-19 cases in the U.S., as signs suggest infections are edging...
Via
Benzinga
Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness
March 29, 2022
President Biden's budget proposal calls for $81.7 billion to spend over five years preparing for future pandemics, which would be a significant investment in boosting the country
Via
Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Earnings, Fed Speakers
March 29, 2022
Pre-open movers
Via
Benzinga
Biotech Funds and ETFs Continue to Lag
March 28, 2022
It’s no secret that market sectors driving inflation are leading the market. With the US economy still strong and the War in Ukraine limiting supply of nat gas and raw materials, producer costs are...
Via
Talk Markets
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
55
56
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.